MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 23, 2007; DOI: 10.1124/mol.106.033324


0026-895X/07/7106-1685-1694$20.00
Mol Pharmacol 71:1685-1694, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.033324v1
71/6/1685    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raoux, M.
Right arrow Articles by Crest, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raoux, M.
Right arrow Articles by Crest, M.

The Amine-Containing Cutaneous Irritant Heptylamine Inhibits the Volume-Regulated Anion Channel and Mobilizes Intracellular Calcium in Normal Human Epidermal Keratinocytes

Matthieu Raoux, Cécile Colomban, Patrick Delmas, and Marcel Crest

Laboratoire de Neurophysiologie Cellulaire, Centre National de la Recherche Scientifique Unité Mixte de Recherche 6150, Université de la Méditerranée, Marseille, France (M.R., P.D., M.C.); Eurofins/ATS, Z. I. des Milles, ACTIMART, Aix en Provence, France (C.C.)

Many amines are skin irritants and cause contact dermatitis. However, little is known about their mechanisms of action in keratinocytes except that they induce the release of the inflammatory mediators cytokines and ATP. Here, we tested whether volume-regulated anion channels (VRACs) in primary cultures of normal human epidermal keratinocytes are modulated by the referenced amine-containing cutaneous irritant heptylamine. Under isotonic conditions, we isolated the VRAC current (IVRAC) from other conductances using a high Ca2+-buffering internal solution. IVRAC ran up after patch rupturing and reached a plateau within 15 min. It was reversibly and dose-dependently inhibited by heptylamine with an IC50 value of 260 µM. Cell-swelling caused by the application of a hypotonic solution increased 2.7-fold IVRAC and reduced the inhibition of VRAC by heptylamine with a dose-response curve shifted approximately 10-fold to the right. In addition, we showed, using cell-attached patch recordings, that adding heptylamine to the bath inhibited VRAC activity. This suggests that heptylamine diffuses into the membrane to inhibit VRAC. Finally, we demonstrated that heptylamine induced Ca2+-store depletion and that VRAC inhibition was not caused by the increase in cytosolic Ca2+. Taken together, these results identify heptylamine as a blocker of VRAC and suggest that Ca2+-store depletion may be involved in mechanisms of irritant contact dermatitis caused by heptylamine.


Received December 10, 2006; accepted March 23, 2007

Address correspondence to: Dr. Marcel Crest, Laboratoire de Neurophysiologie Cellulaire, CNRS UMR 6150, IFR Jean Roche, Faculté de Médecine, Université de la Méditerranée, Boulevard Pierre Dramard, 13916, Marseille Cedex 20, France. E-mail: marcel.crest{at}univmed.fr







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics